Inhibitor Therapeutics, Inc.
INTI
$0.09
$0.0117.03%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.05% | -45.65% | -20.20% | -20.36% | -13.51% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.47% | 18.88% | -18.19% | -5.00% | -7.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -57.35% | -43.77% | -20.14% | -20.00% | -13.37% |
|
|
|||||
| Total Current Assets | -57.35% | -43.77% | -20.14% | -20.00% | -13.37% |
| Net Property, Plant & Equipment | -12.20% | -10.73% | -9.56% | -8.49% | -7.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -55.55% | -42.92% | -19.90% | -19.77% | -13.26% |
|
|
|||||
| Total Accounts Payable | -56.50% | 520.97% | 162.76% | -81.54% | 189.37% |
| Total Accrued Expenses | -71.34% | -95.15% | 1,608.17% | 424.68% | -75.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.31% | 17.41% | -10.18% | 5.77% | 0.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -54.25% | -50.11% | 775.77% | -37.50% | 47.84% |
|
|
|||||
| Total Current Liabilities | -54.25% | -50.11% | 775.77% | -37.50% | 47.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.53% | -20.33% | -16.52% | -15.16% | -10.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -6.31% | -10.29% | 21.44% | -1.89% | 1.23% |
|
|
|||||
| Common Stock & APIC | 0.06% | 0.00% | 0.00% | 0.00% | 0.04% |
| Retained Earnings | -1.09% | -1.24% | -2.39% | -1.33% | -1.25% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.37% | -53.13% | -37,011.43% | -99.51% | -47.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.37% | -53.13% | -37,011.43% | -99.51% | -47.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.37% | -53.13% | -37,011.43% | -99.51% | -47.08% |
|
|
|||||